Andersons pediatric cardiology 2338
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (78.09 KB, 3 trang )
clusteringandmetabolicsyndrome,433–434
diet,425
dyslipidemia,428–431,429t–430t,430f,432b
familyhistoryof,423
high-riskpediatricpatientincludingcongenitalheartdiseasepatients,435–436
hypertension,426–428,427f–428f,427t–428t
inflammatorymarkersof,435
maternalandperinatalfactors,434–435
nursingimplicationsof,437
nutrition,425
overweightandobesity,425–426
pediatricdyslipidemia,managementof,431
pharmacologictherapyforhypertriglyceridemia,433,434f
physicalactivityandsedentarybehavior,425
proproteinconvertasesubtilisin/kexintype9inhibitors,433
statintherapy,431–433,431f–432f
tobacco,423–425
inyouth,423–437
Cardiovascularsupport
forcongenitallymalformedhearts,210
forpulmonaryhypertension,206–207
Cardioverter/defibrillators,implantable,366–367,368f
inFontancirculation,1325–1326
forlongQTsyndrome,354
Carditis,inrheumaticfever,1007–1009,1007b
treatmentof,1017,1017t
Care
barriersto,communicationtoreduce,1488,1489b
congenitalcardiac
dataregistriesin,1510,1511t–1514t
datasourcesin,1509–1510
definingoutcomesin,1509
improvingoutcomesin,1510–1516
throughcarestandardization,1510–1515
throughnetworksandcollaboration,1515–1516,1515t
pathway,defining,1481
Carnitine,deficiencyof,cardiacinvolvementin,1107
Carotidarteries,indiagnosticcatheterization,251
Carotid-femoralpulse-wavevelocity,1365
Case-controlstudies,nested,417
Casereports,415
Catecholaminergicpolymorphicventriculartachycardia(CPVT),354–355,354f
Catecholamines
foracutecirculatoryfailure,1183
forcontrolofcirculation,1357
Catheterablation
electrophysiologyand,360–364,363f
inFontancirculation,1328–1329
forsupraventriculartachycardia,345–346
Cathetermanipulation,240
Catheterization
cardiac,forpulmonaryhypertension,1388
incardiactumors,968
diagnosticandinterventional,anesthesiaandsedationfor,1551–1552
Catheters
forinterventionaltechniques,255
ininvasiveelectrophysiologicstudy,359,360f
Causality,411
fromobservationalstudies,417–418,418b
Cavalvein
anomalousconnectionof,withisomericatrialappendages,444,447f
hepaticveinsand,474
inferior,469–470
anomaliesof,463–464
absenceofhepaticsegmentofinferiorcavalveinwithazygouscontinuationas,463–464,463f–464f
hepaticveintomorphologicallyleftatrium,467
inferiorcavalveinconnectedtoleftatriumas,467,467f
superior,anomaliesof,462–469,462f–463f
absentbilaterallyof,463
absentrightsuperiorcavalveinas,462–463
intra-atrialleftsuperiorcavalveinas,469
leftsuperiorcavalveinconnectedtomorphologicallyleftatrium,464–465
leftsuperiorcavalveindrainingtoleftatriumas,467
leftsuperiorcavalveintocoronarysinus,462,462f
retro-aorticbrachiocephalicvein,469,469f
rightsuperiorcavalveindrainingtoleftatriumas,465–466,466f
systemicvenousreturn,468
CCO,Combinedcardiacoutput
CCSS,ChildhoodCancerSurvivorStudy
Ceftriaxone,forinfectiveendocarditis,1053t
Celltypes,inmyocardialdevelopment,62–66
cardiomyocyte,62,63f
endothelialcells,65–66
fibroblasts,62–64,63f–64f
vascularsmoothmusclecells,64–65,65f
Cellularmetabolism,379–381,381f
Centralnervousmaturity,decreased,incongenitalbraindisease,1396
Centralnervoussystem
evaluationandmonitoringof,inFontanpathway,1290–1291,1291t
extracardiacanomaliesof,452
injury,duringsurgicalrepair,1398b
CentriMagsystem,1187
Centronuclearmyopathy,cardiacinvolvementin,1105
Cerebralflowofblood,altered,incardiopulmonarybypass,232
Cerebralinjury,relatedtocardiopulmonarybypass,229–230
Cerebralmetabolism,incardiopulmonarybypass,232
Cerebralperfusion,antegrade,selective,incardiopulmonarybypass,231
Cerebralprotection,incardiopulmonarybypass,229
Cerebrovascularphysiology,fetal,incomplexcongenitalcardiacdisease,1394–
